Anthrax Lethal Toxin Has Direct and Potent Inhibitory Effects on B Cell Proliferation and Immunoglobulin Production

作者: Hui Fang , Lixin Xu , Trina Y. Chen , Julianne M. Cyr , David M. Frucht

DOI: 10.4049/JIMMUNOL.176.10.6155

关键词:

摘要: Protective host immune responses to anthrax infection in humans and animal models are characterized by the development of neutralizing Abs against receptor-binding protective Ag (PA), which, together with lethal factor (LF) protease, composes toxin (LT). We now report that B cells, turn, targets for LT. Anthrax PA directly binds primary resulting LF-dependent cleavage MAPK kinases (MAPKKs) disrupted signaling downstream targets. Although not LT treatment causes severe cell dysfunction, greatly reducing proliferative IL-4-, anti-IgM-, and/or anti-CD40 stimulation. Moreover, cells treated vitro or isolated from mice vivo have a markedly diminished capacity proliferate produce IgM response TLR-2 TLR-4 ligands. The suppressive effects on function occur at picomolar concentrations sublethal doses vivo. These results indicate inhibits vivo, revealing potential mechanism through which pathogen could bypass responses.

参考文章(45)
T. M. Koehler, Bacillus anthracis Genetics and Virulence Gene Regulation Current Topics in Microbiology and Immunology. ,vol. 271, pp. 143- 164 ,(2002) , 10.1007/978-3-662-05767-4_7
Michael Mourez, Ravi S. Kane, Jeremy Mogridge, Steve Metallo, Pascal Deschatelets, Bret R. Sellman, George M. Whitesides, R. John Collier, Designing a polyvalent inhibitor of anthrax toxin Nature Biotechnology. ,vol. 19, pp. 958- 961 ,(2001) , 10.1038/NBT1001-958
James D. Richards, Shaival H. Davé, Chih-Hao G. Chou, Alusha A. Mamchak, Anthony L. DeFranco, Inhibition of the MEK/ERK Signaling Pathway Blocks a Subset of B Cell Responses to Antigen Journal of Immunology. ,vol. 166, pp. 3855- 3864 ,(2001) , 10.4049/JIMMUNOL.166.6.3855
Hui Fang, Ruth Cordoba-Rodriguez, Carla S. R. Lankford, David M. Frucht, Anthrax Lethal Toxin Blocks MAPK Kinase-Dependent IL-2 Production in CD4+ T Cells The Journal of Immunology. ,vol. 174, pp. 4966- 4971 ,(2005) , 10.4049/JIMMUNOL.174.8.4966
S L Welkos, T J Keener, P H Gibbs, Differences in susceptibility of inbred mice to Bacillus anthracis. Infection and Immunity. ,vol. 51, pp. 795- 800 ,(1986) , 10.1128/IAI.51.3.795-800.1986
Laurence Abrami, Nuria Reig, F. Gisou van der Goot, Anthrax toxin: the long and winding road that leads to the kill Trends in Microbiology. ,vol. 13, pp. 72- 78 ,(2005) , 10.1016/J.TIM.2004.12.004
M Moayeri, The roles of anthrax toxin in pathogenesis. Current Opinion in Microbiology. ,vol. 7, pp. 19- 24 ,(2004) , 10.1016/J.MIB.2003.12.001
Hadar Marcus, Rachel Danieli, Eyal Epstein, Baruch Velan, Avigdor Shafferman, Shaul Reuveny, Contribution of Immunological Memory to Protective Immunity Conferred by a Bacillus anthracis Protective Antigen-Based Vaccine Infection and Immunity. ,vol. 72, pp. 3471- 3477 ,(2004) , 10.1128/IAI.72.6.3471-3477.2004
B. H. Wade, G. G. Wright, E. L. Hewlett, S. H. Leppla, G. L. Mandell, Anthrax toxin components stimulate chemotaxis of human polymorphonuclear neutrophils. Experimental Biology and Medicine. ,vol. 179, pp. 159- 162 ,(1985) , 10.3181/00379727-179-42078
Kenneth A. Bradley, Jeremy Mogridge, Michael Mourez, R. John Collier, John A. T. Young, Identification of the cellular receptor for anthrax toxin. Nature. ,vol. 414, pp. 225- 229 ,(2001) , 10.1038/N35101999